US Edition
News from AdventHealth
We’ve assigned a media bias rating of unknown to AdventHealth. You can read more about our methodology here.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top AdventHealth News
Diabetes) DANVILLE, Pa. - Eight Geisinger hospitals have been named Recognized Leaders in Caring for People Living with Diabetes, a designation bestowed by The Leapfrog Group in collaboration with the American Diabetes Association, (ADA). The national designation recognizes hospitals that provide safe and high-quality health care to inpatients with diabetes based on ADA and other nationally published guidelines. With eight hospitals receiving the recogn…See the Story
The American Diabetes Association and The Leapfrog Group Honor 36 Hospitals for Exceptional Inpatient Care
67% Center coverage: 3 sources
China · ChinaThe sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published by The BMJ today.See the Story
Type 2 Diabetes Drug Shows Improvements for Patients with Progressive Liver Disease
100% Center coverage: 2 sources
